Net profit of Beryl Drugs remain constant at Rs 0.01 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 8.73% to Rs 5.12 crore in the quarter ended September 2025 as against Rs 5.61 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 5.12 | 5.61 | -9 |
| OPM % | 14.26 | 9.98 | - |
| PBDT | 0.65 | 0.44 | 48 |
| PBT | 0.26 | 0.11 | 136 |
| NP | 0.01 | 0.01 | 0 |